Summary

The global Oral Fluid and Saliva Drug Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Oral fluid and saliva drug testing are methods used to detect the presence of drugs or their metabolites in a person's saliva. These tests are commonly used in various settings, including workplaces, law enforcement, and clinical environments, due to their non-invasive nature and ease of administration.
United States market for Oral Fluid and Saliva Drug Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Oral Fluid and Saliva Drug Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Oral Fluid and Saliva Drug Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Oral Fluid and Saliva Drug Testing players cover Abbott, Premier Biotech, OraSure Technologies, MHE, VeriCheck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Oral Fluid and Saliva Drug Testing Industry Forecast” looks at past sales and reviews total world Oral Fluid and Saliva Drug Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral Fluid and Saliva Drug Testing sales for 2026 through 2032. With Oral Fluid and Saliva Drug Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Fluid and Saliva Drug Testing industry.
This Insight Report provides a comprehensive analysis of the global Oral Fluid and Saliva Drug Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Fluid and Saliva Drug Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Fluid and Saliva Drug Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Fluid and Saliva Drug Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Fluid and Saliva Drug Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Fluid and Saliva Drug Testing market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
5 Panels or Less
5 Panel-10 Panel
10 Panels or Above
Segmentation by Application:
Criminal Justice Testing
Workplace Testing
Rehabilitation Therapy
Sports Competition
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Premier Biotech
OraSure Technologies
MHE
VeriCheck
ulti med Products (Deutschland)
Healgen Scientific
Alcolizer
CareHealth America
AlphaBiolabs
AlcoDigital
Azova
Draeger
Securetec Detektions-Systeme
Quest Diagnostics
Oranoxis
Salimetrics
Neogen Corporation
UCP Biosciences
Lin-Zhi International
MEDACX
MediNat
WHPM
AccuBioTech
Assure Tech
Well Biotech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Fluid and Saliva Drug Testing market?
What factors are driving Oral Fluid and Saliva Drug Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Fluid and Saliva Drug Testing market opportunities vary by end market size?
How does Oral Fluid and Saliva Drug Testing break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Oral Fluid and Saliva Drug Testing by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Oral Fluid and Saliva Drug Testing by Country/Region, 2021, 2025 & 2032
2.2 Oral Fluid and Saliva Drug Testing Segment by Type
2.2.1 5 Panels or Less
2.2.2 5 Panel-10 Panel
2.2.3 10 Panels or Above
2.2.4 Oral Fluid and Saliva Drug Testing Sales by Type
2.2.4.1 Global Oral Fluid and Saliva Drug Testing Sales Market Share by Type (2021-2026)
2.2.4.2 Global Oral Fluid and Saliva Drug Testing Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Type (2021-2026)
2.3 Oral Fluid and Saliva Drug Testing Segment by Application
2.3.1 Criminal Justice Testing
2.3.2 Workplace Testing
2.3.3 Rehabilitation Therapy
2.3.4 Sports Competition
2.3.5 Others
2.3.6 Oral Fluid and Saliva Drug Testing Sales by Application
2.3.6.1 Global Oral Fluid and Saliva Drug Testing Sale Market Share by Application (2021-2026)
2.3.6.2 Global Oral Fluid and Saliva Drug Testing Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Application (2021-2026)
3 Global by Company
3.1 Global Oral Fluid and Saliva Drug Testing Breakdown Data by Company
3.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Company (2021-2026)
3.1.2 Global Oral Fluid and Saliva Drug Testing Sales Market Share by Company (2021-2026)
3.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Company (2021-2026)
3.2.1 Global Oral Fluid and Saliva Drug Testing Revenue by Company (2021-2026)
3.2.2 Global Oral Fluid and Saliva Drug Testing Revenue Market Share by Company (2021-2026)
3.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Company
3.4 Key Manufacturers Oral Fluid and Saliva Drug Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Fluid and Saliva Drug Testing Product Location Distribution
3.4.2 Players Oral Fluid and Saliva Drug Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Oral Fluid and Saliva Drug Testing by Geographic Region
4.1 World Historic Oral Fluid and Saliva Drug Testing Market Size by Geographic Region (2021-2026)
4.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oral Fluid and Saliva Drug Testing Market Size by Country/Region (2021-2026)
4.2.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Country/Region (2021-2026)
4.2.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral Fluid and Saliva Drug Testing Sales Growth
4.4 APAC Oral Fluid and Saliva Drug Testing Sales Growth
4.5 Europe Oral Fluid and Saliva Drug Testing Sales Growth
4.6 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales Growth
5 Americas
5.1 Americas Oral Fluid and Saliva Drug Testing Sales by Country
5.1.1 Americas Oral Fluid and Saliva Drug Testing Sales by Country (2021-2026)
5.1.2 Americas Oral Fluid and Saliva Drug Testing Revenue by Country (2021-2026)
5.2 Americas Oral Fluid and Saliva Drug Testing Sales by Type (2021-2026)
5.3 Americas Oral Fluid and Saliva Drug Testing Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Fluid and Saliva Drug Testing Sales by Region
6.1.1 APAC Oral Fluid and Saliva Drug Testing Sales by Region (2021-2026)
6.1.2 APAC Oral Fluid and Saliva Drug Testing Revenue by Region (2021-2026)
6.2 APAC Oral Fluid and Saliva Drug Testing Sales by Type (2021-2026)
6.3 APAC Oral Fluid and Saliva Drug Testing Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Fluid and Saliva Drug Testing by Country
7.1.1 Europe Oral Fluid and Saliva Drug Testing Sales by Country (2021-2026)
7.1.2 Europe Oral Fluid and Saliva Drug Testing Revenue by Country (2021-2026)
7.2 Europe Oral Fluid and Saliva Drug Testing Sales by Type (2021-2026)
7.3 Europe Oral Fluid and Saliva Drug Testing Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Fluid and Saliva Drug Testing by Country
8.1.1 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Country (2021-2026)
8.1.2 Middle East & Africa Oral Fluid and Saliva Drug Testing Revenue by Country (2021-2026)
8.2 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Type (2021-2026)
8.3 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Fluid and Saliva Drug Testing
10.3 Manufacturing Process Analysis of Oral Fluid and Saliva Drug Testing
10.4 Industry Chain Structure of Oral Fluid and Saliva Drug Testing
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Fluid and Saliva Drug Testing Distributors
11.3 Oral Fluid and Saliva Drug Testing Customer
12 World Forecast Review for Oral Fluid and Saliva Drug Testing by Geographic Region
12.1 Global Oral Fluid and Saliva Drug Testing Market Size Forecast by Region
12.1.1 Global Oral Fluid and Saliva Drug Testing Forecast by Region (2027-2032)
12.1.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oral Fluid and Saliva Drug Testing Forecast by Type (2027-2032)
12.7 Global Oral Fluid and Saliva Drug Testing Forecast by Application (2027-2032)
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.1.3 Abbott Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Premier Biotech
13.2.1 Premier Biotech Company Information
13.2.2 Premier Biotech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.2.3 Premier Biotech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Premier Biotech Main Business Overview
13.2.5 Premier Biotech Latest Developments
13.3 OraSure Technologies
13.3.1 OraSure Technologies Company Information
13.3.2 OraSure Technologies Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.3.3 OraSure Technologies Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 OraSure Technologies Main Business Overview
13.3.5 OraSure Technologies Latest Developments
13.4 MHE
13.4.1 MHE Company Information
13.4.2 MHE Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.4.3 MHE Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MHE Main Business Overview
13.4.5 MHE Latest Developments
13.5 VeriChe

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Oral Fluid and Saliva Drug Testing Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oral Fluid and Saliva Drug Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 5 Panels or Less
Table 4. Major Players of 5 Panel-10 Panel
Table 5. Major Players of 10 Panels or Above
Table 6. Global Oral Fluid and Saliva Drug Testing Sales by Type (2021-2026) & (K Units)
Table 7. Global Oral Fluid and Saliva Drug Testing Sales Market Share by Type (2021-2026)
Table 8. Global Oral Fluid and Saliva Drug Testing Revenue by Type (2021-2026) & ($ million)
Table 9. Global Oral Fluid and Saliva Drug Testing Revenue Market Share by Type (2021-2026)
Table 10. Global Oral Fluid and Saliva Drug Testing Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Oral Fluid and Saliva Drug Testing Sale by Application (2021-2026) & (K Units)
Table 12. Global Oral Fluid and Saliva Drug Testing Sale Market Share by Application (2021-2026)
Table 13. Global Oral Fluid and Saliva Drug Testing Revenue by Application (2021-2026) & ($ million)
Table 14. Global Oral Fluid and Saliva Drug Testing Revenue Market Share by Application (2021-2026)
Table 15. Global Oral Fluid and Saliva Drug Testing Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Oral Fluid and Saliva Drug Testing Sales by Company (2021-2026) & (K Units)
Table 17. Global Oral Fluid and Saliva Drug Testing Sales Market Share by Company (2021-2026)
Table 18. Global Oral Fluid and Saliva Drug Testing Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Oral Fluid and Saliva Drug Testing Revenue Market Share by Company (2021-2026)
Table 20. Global Oral Fluid and Saliva Drug Testing Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Oral Fluid and Saliva Drug Testing Producing Area Distribution and Sales Area
Table 22. Players Oral Fluid and Saliva Drug Testing Products Offered
Table 23. Oral Fluid and Saliva Drug Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Oral Fluid and Saliva Drug Testing Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Oral Fluid and Saliva Drug Testing Sales Market Share Geographic Region (2021-2026)
Table 28. Global Oral Fluid and Saliva Drug Testing Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Oral Fluid and Saliva Drug Testing Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Oral Fluid and Saliva Drug Testing Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Oral Fluid and Saliva Drug Testing Sales Market Share by Country/Region (2021-2026)
Table 32. Global Oral Fluid and Saliva Drug Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Oral Fluid and Saliva Drug Testing Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Oral Fluid and Saliva Drug Testing Sales by Country (2021-2026) & (K Units)
Table 35. Americas Oral Fluid and Saliva Drug Testing Sales Market Share by Country (2021-2026)
Table 36. Americas Oral Fluid and Saliva Drug Testing Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Oral Fluid and Saliva Drug Testing Sales by Type (2021-2026) & (K Units)
Table 38. Americas Oral Fluid and Saliva Drug Testing Sales by Application (2021-2026) & (K Units)
Table 39. APAC Oral Fluid and Saliva Drug Testing Sales by Region (2021-2026) & (K Units)
Table 40. APAC Oral Fluid and Saliva Drug Testing Sales Market Share by Region (2021-2026)
Table 41. APAC Oral Fluid and Saliva Drug Testing Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Oral Fluid and Saliva Drug Testing Sales by Type (2021-2026) & (K Units)
Table 43. APAC Oral Fluid and Saliva Drug Testing Sales by Application (2021-2026) & (K Units)
Table 44. Europe Oral Fluid and Saliva Drug Testing Sales by Country (2021-2026) & (K Units)
Table 45. Europe Oral Fluid and Saliva Drug Testing Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Oral Fluid and Saliva Drug Testing Sales by Type (2021-2026) & (K Units)
Table 47. Europe Oral Fluid and Saliva Drug Testing Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Oral Fluid and Saliva Drug Testing Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Oral Fluid and Saliva Drug Testing
Table 53. Key Market Challenges & Risks of Oral Fluid and Saliva Drug Testing
Table 54. Key Industry Trends of Oral Fluid and Saliva Drug Testing
Table 55. Oral Fluid and Saliva Drug Testing Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Oral Fluid and Saliva Drug Testing Distributors List
Table 58. Oral Fluid and Saliva Drug Testing Customer List
Table 59. Global Oral Fluid and Saliva Drug Testing Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Oral Fluid and Saliva Drug Testing Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Oral Fluid and Saliva Drug Testing Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Oral Fluid and Saliva Drug Testing Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Oral Fluid and Saliva Drug Testing Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Oral Fluid and Saliva Drug Testing Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Oral Fluid and Saliva Drug Testing Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Oral Fluid and Saliva Drug Testing Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Oral Fluid and Saliva Drug Testing Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Oral Fluid and Saliva Drug Testing Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Oral Fluid and Saliva Drug Testing Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Oral Fluid and Saliva Drug Testing Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Oral Fluid and Saliva Drug Testing Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Oral Fluid and Saliva Drug Testing Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Abbott Basic Information, Oral Fluid and Saliva Drug Testing Manufacturing Base, Sales Area and Its Competitors
Table 74. Abbott Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
Table 75. Abbott Oral Fluid and Saliva Drug Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Abbott Main Business
Table 77. Abbott Latest Developments
Table 78. Premier Biotech Basic Information, Oral Fluid and Saliva Drug Testing Manufacturing Base, Sales Area and Its Competitors
Table 79. Premier Biotech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
Table 80. Premier Biotech Oral Fluid and Saliva Drug Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Premier Biotech Main Business
Table 82. Premier Biotech Latest Developments
Table 83. OraSure Technologies Basic Information, Oral Fluid and Saliva Drug Testing Manufacturing Base, Sales Area and Its Competitors
Table 84. OraSure Technologies Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
Table 85. OraSure Technologies Oral Fluid and Saliva Drug Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. OraSure Technologies Main Business
Table 87. OraSure Technologies Latest Developments
Table 88. MHE Basic Information, Oral Fluid and Saliva